By the bioMérieux Connection Editors
In February’s issue of CAP TODAY, the magazine profiles bioMérieux’s Christine Ginocchio, PhD, MT, who was recently appointed to the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB). Dr. Ginocchio is the first voting member of PACCARB from the in vitro diagnostics industry, which demonstrates the vital role innovative diagnostics play in the battle against antibiotic resistance and preserving antibiotic efficacy for future generations.
“While the development of new antibiotic drugs is vital, we too often overlook the essential role diagnostics will play, and in fact are playing, to curtail antibiotic misuse,” Dr. Ginocchio told CAP TODAY. “The moment has come to recognize that the effectiveness of antimicrobial prescribing in general and of stewardship programs in particular is highly dependent on the quality, availability, timeliness, and accuracy of diagnostic microbiology results.”
Dr. Ginocchio serves as Vice President of Global Medical Affairs for bioMérieux and BioFire Diagnostics. Prior to joining bioMérieux, she was Senior Medical Director and Chief, Division of Infectious Disease Diagnostics at North Shore-Long Island Jewish Health System Laboratories (now Northwell Health).
For more highlights from February’s issue, visit CAP TODAY’s website.
Opinions expressed in this article are not necessarily those of bioMérieux, Inc.